The scientists at Eli Lilly and Company are advancing towards viable treatment options for those with early-stage Alzheimer's disease. However, the current policy framework in Washington is not ready for a shift in Alzheimer's treatment. Through the Alzheimer's Readiness Project, Eli Lilly set out to support the grassroots patient advocacy that shapes our healthcare policy. Patients are often the best advocates; thus the campaign provided digital toolkits for patients to share with Congress. We supported the efforts with a geo-targeted digital ad campaign, an interactive website, video ads, and supporting materials and white papers.